Monthly Archives: February 2020

Lawsuit for Investors in Pareteum Corporation (NASDAQ: TEUM) announced by Shareholders Foundation

SAN DIEGO, CA / ACCESSWIRE / February 25, 2020 / The Shareholders Foundation, Inc. announces that a lawsuit was filed for certain investors in Pareteum Corporation (NASDAQ:TEUM) shares.

Investors, who purchased shares of Pareteum Corporation (NASDAQ:TEUM), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554.

The plaintiff alleges that the defendants made false and/or misleading statements and/or failed to disclose that Pareteum improperly and inaccurately recognized revenue for certain customer transactions, that Pareteum's financial statements for the fiscal year ending December 31, 2018 and quarters of ending March 31, 2019 and June 30, 2019 were false and could not be relied on, and that as a result, defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

Those who purchased Pareteum Corporation (NASDAQ:TEUM) shares should contact the Shareholders Foundation, Inc.

CONTACT:

Shareholders Foundation, Inc.
Michael Daniels
+1 (858) 779-1554
mail@shareholdersfoundation.com
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108

The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. Any referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is only provided as a public service. It is not intended as legal advice and should not be relied upon.

SOURCE: Shareholders Foundation, Inc.

ReleaseID: 577721

Lawsuit for Investors in shares of Sealed Air Corporation (NYSE: SEE) announced by Shareholders Foundation

SAN DIEGO, CA / ACCESSWIRE / February 25, 2020 / The Shareholders Foundation, Inc. announces that a lawsuit was filed for certain investors in Merit Sealed Air Corporation (NYSE:SEE) shares.

Investors, who purchased shares of Sealed Air Corporation (NYSE:SEE), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554.

The plaintiff alleges that the defendants made false and misleading statements and/or failed to disclose adverse information regarding Sealed Air's business, operations, and financial condition. Specifically, defendants failed to disclose that Sealed Air's deduction of $1.49 billion in connection with a settlement of asbestos liabilities was indefensible and done for the improper purpose of artificially inflating Sealed Air's financial results; that Sealed Air had switched auditors pursuant to a conflicted and improper process and in order to help facilitate defendants' efforts to engage in accounting fraud; and that Sealed Air had artificially inflated its earnings, cash flows, and operating income between November 5, 2014 and August 6, 2018..

Those who purchased Sealed Air Corporation (NYSE:SEE) shares should contact the Shareholders Foundation, Inc.

CONTACT:

Shareholders Foundation, Inc.
Michael Daniels
+1 (858) 779-1554
mail@shareholdersfoundation.com
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108

The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. Any referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is only provided as a public service. It is not intended as legal advice and should not be relied upon.

SOURCE: Shareholders Foundation, Inc.

ReleaseID: 577720

Lawsuit for Investors in Pattern Energy Group Inc. (NASDAQ:PEGI) announced by Shareholders Foundation

SAN DIEGO, CA / ACCESSWIRE / February 25, 2020 / The Shareholders Foundation, Inc. announces that a lawsuit was filed for certain investors in Pattern Energy Group Inc. (NASDAQ:PEGI) shares in connection with proposed takeover of Pattern Energy Group Inc. by Canada Pension Plan Investment Board.

Investors, who purchased shares of Pattern Energy Group Inc. (NASDAQ:PEGI), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554.

On November 4, 2019, Pattern Energy Group Inc announced that it had entered into an agreement to be acquired by Canada Pension Plan Investment Board at a price of $26.75 per share in cash.

However, the plaintiff alleges that the defendants violated Sections 14(a) and 20(a) of the Securities Exchange Act of 1934 by causing a materially incomplete and misleading preliminary proxy statement to be filed with the United States Securities and Exchange Commission on December 13, 2019.

Among other things, the plaintiff also alleges that the proposed transaction is riddled with conflicts of interest given Pattern Energy Group's relationship with Pattern Energy Group 2 LP and Riverstone Pattern Energy Holdings II, L.P, that the Board of Directors of Pattern Energy Group Inc has also voted in favor of a proposal for lucrative compensation to Pattern Energy Group's executive officers.

Those who purchased Pattern Energy Group Inc. (NASDAQ:PEGI) shares should contact the Shareholders Foundation, Inc.

CONTACT:

Shareholders Foundation, Inc.
Michael Daniels
+1 (858) 779-1554
mail@shareholdersfoundation.com
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108

The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. Any referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is only provided as a public service. It is not intended as legal advice and should not be relied upon.

SOURCE: Shareholders Foundation, Inc.

ReleaseID: 577719

Hersha Hospitality Trust

NEW YORK, NY / ACCESSWIRE / February 25, 2020 / Hersha Hospitality Trust (NYSE:HT) will be discussing their earnings results in their 2019 Fourth Quarter Earnings call to be held on February 25, 2020 at 9:00 AM Eastern Time.

To listen to the event live or access a replay of the call – visit https://www.investornetwork.com/event/presentation/58783

To receive updates for this company you can register by emailing info@investornetwork.com or by clicking get investment info from the company's profile.

About Investor Network

Investor Network (IN) is a financial content community, serving millions of unique investors market information, earnings, commentary and news on the what's trending. Dedicated to both the professional and the average traders, IN offers timely, trusted and relevant financial information for virtually every investor. IN is an Issuer Direct brand, to learn more or for the latest financial news and market information, visit www.investornetwork.com. Follow us on Twitter @investornetwork.

SOURCE: Investor Network

ReleaseID: 577713

Avanos Medical, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / February 25, 2020 / Avanos Medical, Inc. (NYSE:AVNS) will be discussing their earnings results in their 2019 Fourth Quarter Earnings call to be held on February 25, 2020 at 9:00 AM Eastern Time.

To listen to the event live or access a replay of the call – visit https://www.investornetwork.com/event/presentation/59384

To receive updates for this company you can register by emailing info@investornetwork.com or by clicking get investment info from the company's profile.

About Investor Network

Investor Network (IN) is a financial content community, serving millions of unique investors market information, earnings, commentary and news on the what's trending. Dedicated to both the professional and the average traders, IN offers timely, trusted and relevant financial information for virtually every investor. IN is an Issuer Direct brand, to learn more or for the latest financial news and market information, visit www.investornetwork.com. Follow us on Twitter @investornetwork.

SOURCE: Investor Network

ReleaseID: 577712

Cooper-Standard Holdings, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / February 25, 2020 / Cooper-Standard Holdings, Inc. (NYSE:CPS) will be discussing their earnings results in their 2019 Fourth Quarter Earnings call to be held on February 25, 2020 at 9:00 AM Eastern Time.

To listen to the event live or access a replay of the call – visit https://www.investornetwork.com/event/presentation/59326

To receive updates for this company you can register by emailing info@investornetwork.com or by clicking get investment info from the company's profile.

About Investor Network

Investor Network (IN) is a financial content community, serving millions of unique investors market information, earnings, commentary and news on the what's trending. Dedicated to both the professional and the average traders, IN offers timely, trusted and relevant financial information for virtually every investor. IN is an Issuer Direct brand, to learn more or for the latest financial news and market information, visit www.investornetwork.com. Follow us on Twitter @investornetwork.

SOURCE: Investor Network

ReleaseID: 577711

PPX Discovers New High-Grade Ore Shoot at Mina Callanquitas: Samples 1.2m Grading 71.93 gpt Au, 336 gpt Ag

VANCOUVER, BC / ACCESSWIRE / February 25, 2020 / PPX Mining Corp. (the "Company" or "PPX") is pleased to announce that development work on the 3290 level of Mina Callanquitas has cut a high-grade ore shoot within the previously defined reserves for Mina Callanquitas (please see press release dated December 4, 2018 and Pre-Feasibility Study posted on SEDAR), an area of the mine where surface exploration drilling produced only modest results. Systematic underground channel sampling, part of the Company's normal ore control protocol, outlined a high-grade ore shoot over a strike length of 78 metres with a true width of 1.6 metres. The average grade over this area, based on 62 channel samples, is 14.32 gpt Au and 146 gpt Ag. Individual samples contained up 71.93 gpt Au and 1042 gpt Ag as described in more detail below. Higher than anticipated grades and good ore continuity highlight the significance of this discovery:

The two diamond core drill holes nearest the 3290 level ore shoot contained 5.50 and 6.56 gpt Au (CA-12-42 and -43, please see diagram below and on the Company's website). In contrast, the 62 channel samples ranged from 2.12 to 71.93 gpt gold yielding a weighted average true thickness of 1.6 metres grading 14.32 gpt gold over a strike length of 78 metres. The results for Ag are more striking, the drill holes contained 21.1 and 10.1 gpt Ag, while the channel samples ranged from 27.9 to 1042 gpt Ag. Precious metal mineralization in this portion of Mina Callanquitas is completely oxidized and it is possible that some of the silver oxide minerals were not adequately recovered or sampled in the core drilling process. As has been noted previously (please see PPX Press Release dated February 5, 2020), the Au grade of ore delivered to the Malin Plant of Silver Cascas S.A.C., has consistently been higher than the grades shown in the Company's reserve and resource model. The sampling also demonstrates good continuity within the ore shoot, an important characteristic in mine planning and exploitation.
The 3290 level cuts the Callanquitas ore body in an area above a high-grade ore chute defined by previous diamond core drilling. Drill holes CA-11-08, -11, CA-12-19, -30, -31, -55, and CA-17-86 outline an area with a strike length in excess of 150 metres over a similar vertical range that grades between 13.78 and 102.0 gpt Au Eq (please see diagram below and on the Company's website). The 3290 level ore shoot is a vertical continuation of this ore chute and expands the vertical range of the ore shoot to a minimum of 200 metres. The down dip continuation of this zone is unconstrained by drilling.
As shown in the longitudinal section below, other high-grade ore shoots have been identified by surface diamond drilling. The 3290 ore shoot confirms the earlier diamond drilling results and supports an exploration/development model that focuses on the drill defined areas of higher grade that could increase resource and reserve ounces.

Brian J. Maher, President and CEO of PPX Mining Corp commented: "The underground sampling results from the 3290 level provide verification of the tenor and volume of high-grade gold and silver ore shoots at Mina Callanquitas. The high grades, couple with elevated gold and silver prices, provide opportunities to optimize mine planning. The existing NI 43-101 Pre-Feasibility Study utilized a $1250 gold price and a life of mine average grade of only 4.66 gpt Au Eq, clearly current metal prices and confirmation of the high-grade ore shoots presents a significant economic opportunity for the Company."

Channel sampling protocols and QA/QC: PPX Mining geologists collect channel samples underground on each working face prior to advancing the excavation. Samples are collected orthogonal to the structure edge or boundary and do not exceed 2.0 metres in length. Channels are broken at obvious geologic boundaries to correctly separate rock types, mineralization styles and hydrothermal alteration assemblages. The samples are collected by cutting a channel approximately 2.5 cm deep by 25 cm wide along a line painted on the face by the mine geologist. Sample weight is typically 1.5 to 2.5 kg. Samples are sealed, labeled and stored in a secure area prior to shipment to a qualified assay laboratory. Gold and silver analyses are conducted by the fire assay method with a CN leach. Blanks and standards are inserted approximately every 15 samples; duplicate channel samples are included at the same intervals. Duplicate fire assays for approximately every 30 samples are sent to a second assay laboratory for umpire analysis

About PPX Mining Corp: PPX Mining Corp. (TSX.V: PPX.V, SSE: PPX, BVL: PPX) is a Canadian-based mining company with assets in northern Peru. Igor, the Company's 100%-owned flagship gold and silver project, is located in the prolific Northern Peru gold belt in eastern La Libertad Department. PPX is developing the Callanquitas Mine and heap leach facility to exploit high grade, underground-minable gold and silver ore. Based on the Company's Pre-Feasibility Study ("PFS"), PPX expects the Callanquitas Mine to produce up to 26,000 AuEq* ounces per year over a seven-year mine life at cash cost of less than US$610/AuEq* ounce (the Igor PFS is available on the Company's website and SEDAR). Simultaneously, PPX is accelerating its exploration program at Igor in order to fully evaluate the resource potential of the entire Igor project area. The Callanquitas structure is open along strike and at depth, parallel structures are unexplored. New discoveries at Portachuelos, coupled with the Domo and Tesoros exploration targets, emphasize that the Igor Project is evolving into a district-scale project with multiple deposits and mineralized zones.

*AuEq is calculated as follows: AuEq ounces = Au ounces + Ag ounces/75. Per PFS, inclusive of metallurgical recovery.

All scientific and technical information in this press release has been reviewed and approved by Quentin J. Browne, P.Geo., Independent Consulting Geologist to PPX Mining Corp., who is a qualified person under the definitions established by National Instrument 43-101.

On behalf of the Board of Directors
Brian J. Maher
President and Chief Executive Officer

FOR FURTHER INFORMATION, PLEASE CONTACT:

PPX Mining Corp.
Brian J. Maher, President and Chief Executive Officer
Phone: 1-530-913-4728
Email: brian.maher@ppxmining.com
Website: www.ppxmining.com

 

Cautionary Statement:

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Certain disclosure in this release, June constitute "forward-looking statements" within the meaning of the United States Private Securities Litigation Reform Act of 1995 and Canadian securities legislation. In making the forward-looking statements in this release, the Company has applied certain factors and assumptions that the Company believes are reasonable. However, the forward-looking statements in this release are subject to numerous risks, uncertainties and other factors that June cause future results to differ materially from those expressed or implied in such forward-looking statements. Such uncertainties and risks are detailed from time to time in the Company's filings with the appropriate securities commissions, and June include, among others, market conditions, and delays in obtaining or failure to obtain required regulatory approvals or financing. There can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements. Readers are cautioned not to place undue reliance on forward-looking statements. The Company does not intend, and expressly disclaims any intention or obligation to, update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by law.

SOURCE: PPX Mining Corp.

ReleaseID: 577683

Theralase Advances Its Pivotal Phase II Non-Muscle Invasive Bladder Cancer Study with a New Clinical Study Site in Nova Scotia

TORONTO, ON / ACCESSWIRE / February 25, 2020 / Theralase® Technologies Inc. ("Theralase" or the "Company") (TSXV:TLT)(OTCQB: TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light activated Photo Dynamic Compounds ("PDC") and associated drug formulations, announced that Nova Scotia Health Authority ("NSHA") Research Ethics Board ("REB") has approved the commencement of a Pivotal Phase II Non-Muscle Invasive Bladder Cancer ("NMIBC") Clinical Study to enroll and treat patients who present with Carcinoma In-Situ ("CIS") and who are considered Bacillus Calmette Guerin("BCG")-Unresponsive or are intolerant to BCG Therapy ("Study II").

The Nova Scotia provincial cancer rates are among the highest in Canada. It is estimated for 2019 in Nova Scotia that 6,700 people were diagnosed with cancer, and 2,900 people died of cancer1 with bladder cancer cases counting for approximately 5% of cancer diagnosis.2

The NSHA institution is affiliated with the Urology Department at Dalhousie ("UDD") University of Medicine, an innovative leader in urological oncology research. UDD evaluates new technologies designed to improve the lives of people suffering from urological cancers. Each year, more than 300 people are diagnosed with bladder cancer and seek attention in Nova Scotia.2 UDD doctors have extensive experience providing quality of care for bladder cancer patients while maintaining an active research role to enhance overall patient care.

Dr. Ricardo Rendon, MD, FRCSC, Professor in the Department of Urology and Director of Clinical Trial of Dalhousie University in Halifax stated that "We are excited to work with Theralase for the NMIBC clinical trial. Tackling cancer is a crucial topic and a priority for this region, and I am pleased that NSHA is able to contribute to the growth of innovative cancer research by taking part in this leading Pivotal PhotoDynamic Therapy ("PDT") study."

With the addition of NSHA, the Company now has four sites open for patient enrollment and treatment, specifically, NSHA, London Health Science Centre ("LHSC"), University Health Network ("UHN") and McGill University Health Centre ("MUHC"). In addition, the Company has approximately 16 clinical study sites located in Canada and the US that are at various stages of the on-boarding process. The Company is strategically targeting clinical sites throughout Canada and the US (subject to FDA Investigational New Drug ("IND") approval) that serve large populations or have the demographics to support patient enrollment and treatment.

Shawn Shirazi, Ph.D., CEO of Theralase, stated that "I am pleased to announce the addition of NSHA and Dr. Rendon as Principal Investigator. Dr. Rendon is considered an expert in the field with a clinical focus on all areas of uro-oncology. To date, 10 patients have been treated, which represents a 10% completion rate of patient enrollment, and about a 50% completion rate in relation to the interim analysis milestone set at treating 20 to 25 patients. By continuing to advance Study II, we hope to bring this treatment to all Canadian patients suffering from this disease and look forward to starting our clinical study in the US, subject to regulatory approval."

About Study II

The Phase II NMIBC Clinical Study utilizes the Therapeutic Dose (0.70 mg/cm2) of TLD-1433, focusing on the treatment of approximately 100 BCG-Unresponsive NMIBC patients presenting with CIS in approximately 20 clinical study sites located in Canada and the US. Study II will have a primary endpoint of efficacy (measured by CR) at any point in time, a secondary endpoint of duration of CR at approximately 360 days post-initial treatment and a tertiary endpoint of safety measured by incidence and severity of adverse events grade 4 or higher that do not resolve within 360 days post-initial treatment. To date, 4 clinical study sites are active for enrollment and 10 patients have been treated in the Study II.

About NMIBC:

In 2020, an estimated 81,400 adults (62,100 men and 19,300 women) will be newly diagnosed with bladder cancer in the United States. Among men, bladder cancer is the fourth most common cancer. It is estimated that 17,980 deaths (13,050 men and 4,930 women) from this disease will occur in 2020.3 The bladder cancer market is expected to triple in size to around $1.1 billion by 2025.4

About Theralase® Technologies Inc.

Theralase® is a clinical stage pharmaceutical company dedicated to the research and development of light activated Photo Dynamic Compounds and their associated drug formulations intended to safely and effectively destroy various cancers.

Additional information is available at www.theralase.com and www.sedar.com

1 Canadian Cancer Statistics Publication, Nova Scotia cancer statistics at a glance. https://www.cancer.ca/en/cancer-information/cancer-101/canadian-cancer-statistics-publication/?region=ns. Accessed January 29, 2020.

2 Canadian Cancer Statistics – 2019. http://www.cancer.ca/~/media/cancer.ca/CW/publications/Canadian%20Cancer%20Statistics/Canadian-Cancer-Statistics-2019-EN.pdf. Accessed January 29, 2020.

3 Key Statistics for Bladder Cancer. https://www.cancer.org/cancer/bladder-cancer/about/key-statistics.html. Accessed January 29, 2020.

4 Bladder cancer market size to more than triple to over $1.1 billion by 2025. (2017). Retrieved 14 August 2019, from https://www.globaldata.com/bladder-cancer-market-size-triple-1-1-billion-2025/

Forward Looking Statement:

This news release contains "forward-looking statements" which reflect the current expectations of the Company's Management for future growth, results of operations, performance, business prospects and opportunities. Such statements include, but are not limited to, statements regarding the Company's proposed development plans with respect to Photo Dynamic Compounds and their drug formulations. Wherever possible, words such as "may", "would", "could", "should", "will", "anticipate", "believe", "plan", "expect", "intend", "estimate", "potential for" and similar expressions have been used to identify these forward-looking statements. These statements reflect management's current beliefs with respect to future events and are based on information currently available to management. Forward-looking statements involve significant risks, uncertainties and assumptions including with respect to the ability of the Company to adequately fund, secure the requisite regulatory approvals to commence and successfully complete a Phase II NMIBC clinical study in a timely fashion and implement its development plans. Many factors could cause the Company's actual results, performance or achievements to be materially different from any future results, performance or achievements that may be expressed or implied by such forward-looking statements; including, without limitation, those listed in the filings made by the Company with the Canadian securities regulatory authorities (which may be viewed at www.sedar.com). Should one or more of these risks or uncertainties materialize or should assumptions underlying the forward-looking statements prove incorrect, actual results, performance or achievements may vary materially from those expressed or implied by the forward-looking statements contained in this news release. These factors should be considered carefully, and prospective investors should not place undue reliance on the forward-looking statements. Although the forward-looking statements contained in the press release are based upon what management currently believes to be reasonable assumptions, the Company cannot assure prospective investors that actual results, performance or achievements will be consistent with these forward-looking statements. The Company disclaims any intention or obligation to revise forward-looking statements whether as a result of new information, future developments or otherwise except as required by law. All forward-looking statements are expressly qualified in their entirety by this cautionary statement. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchanges) accepts responsibility for the adequacy or accuracy of this release.

For More Information:

1.866.THE.LASE (843-5273)
www.theralase.com
Shushu Feng, Investor Relations & Public Relations Coordinator
sfeng@theralase.com
Amelia Tudo, Investor Relations & Public Relations Coordinator
atudo@theralase.com

SOURCE: Theralase Technologies Inc.

ReleaseID: 577676

Galway Metals Intersects 10.6 g/t Au Over 47.0m (25.6mTW) South of the Richard Zone; 4.5 g/t Au over 10.8m (5.6mTW) Narrows Gap Between Richard and Jubilee at Clarence Stream

TORONTO, ONTARIO / ACCESSWIRE / February 25, 2020 / Galway Metals Inc. (TSX-V:GWM) (the "Company" or "Galway") is pleased to report assay results from drilling south of the Richard Zone in that area, and between the Richard and Jubilee Zones at the Company's Clarence Stream project in southwest New Brunswick, Canada (Figure 1 and Figure 2). The latest results are highlighted by the following 3 drill holes:

Hole 87 intersected 10.6 g/t Au over 47.0m, plus 1.2 g/t Au over 32.0m. The two intervals in hole 87 line up well, and between previously-released step-out holes 72 and 78, located 22 metres northeast and 116 metres southwest, respectively. Hole 72 contained 20.7 g/t Au over 9.5m, plus 4.6 g/t Au over 29.65m, while hole 78 hosted 20.9 g/t Au over 4.75m, plus 2.7 g/t Au over 14.1m (Figure 2, Figure 3, Figure 4, and Figure 5).
Hole 93 extends the Richard Zone 97m to the southwest with an intersection that ran 4.5 g/t Au over 10.8m. This intersect is open immediately above the first sample, which ran 33.2 g/t Au over 1.05m, as only partial assays have been received. With this intersect, the gap between the Richard and Jubilee Zones has narrowed to 350m from 1-km originally. Galway continues to receive evidence from drill results that the GMZ, Richard and Jubilee Zones are part of the same 2.5 km-long mineralized system. Refer to the February 13, 2020 press release that noted an extension of the GMZ 230m toward Richard.
Hole 81 intersected 0.8 g/t Au over 23.0m and is located 122m below and west of previous-released hole 68, which returned 3.0 g/t Au over 12.0m. Hole 68 extended the Jubilee Zone 227m northeast toward the Richard Zone.

Robert Hinchcliffe, President and CEO of Galway Metals, said, "The wide and high-grade intersection in hole 87 is among the best in the company's history. Its location between two other wide and high grade intersects bodes very well for the Clarence Stream resource update scheduled for the 3rd quarter of 2020, both from the perspective of any pit-constrained or underground resource. Hole 93 is significant because it continues the process of closing the gap between the Richard and Jubilee Zones, just as the previous press release of two weeks ago closed the gap between the GMZ and Richard Zones. Of note is that NONE of the 36,377 metres of drilling that Galway has completed in the 2.5-km-long mineralized system that hosts the George Murphy, Richard and Jubilee Zones are in the existing Clarence Stream resource, which was last updated 2.5 years ago on September 26, 2017. That resource includes the South and North Zones only. All five deposits remain open for expansion in all directions. Galway's strong drill results demonstrate that Clarence Stream is an emerging new gold district in North America."

Drill Hole Highlights

20BL-87: 10.6 grams per tonne (g/t) Au over 47.0 metres (m) (including 495.0 g/t Au over 0.5m, 67.8 g/t Au over 0.55m, 57.9 g/t Au over 0.5m, 51.6 g/t Au over 0.65m, 42.4 g/t Au over 0.75m, 35.7 g/t Au over 0.85m, 21.3 g/t Au over 0.8m, and 20.6 g/t Au over 0.5m), plus 1.2 g/t Au over 32.0m (including 10.9 g/t Au over 1.0m, 9.9 g/t Au over 0.7m, and 3.8 g/t Au over 1.0m) starting at vertical depths of 151m and 105m below surface
**19BL-72: 20.7 g/t Au over 9.5m (including 92.0 g/t Au over 0.75m, 51.9 g/t Au over 0.9m, and 23.5 g/t Au over 1.1m) plus 4.6 g/t Au over 29.65m (including 63.6 g/t Au over 0.8m, 49.1 g/t Au over 0.5m, 17.5 g/t Au over 0.75m, and 20.2 g/t Au over 1.0m) starting at vertical depths of 185m and 128m below surface
**19BL-78: 20.9 g/t Au over 4.75m (including 54.5 g/t Au over 0.9m and 64.6 g/t Au over 0.6m), plus 2.7 g/t Au over 14.1m (including 15.7 g/t Au over 1.15m and 12.6 g/t Au over 0.65m) starting at vertical depths of 124m and 95m below surface
20BL-93: 4.5 g/t Au over 10.8m (including 33.2 g/t Au over 1.05m) starting at a vertical depth of 178m below surface
19BL-81: 0.8 g/t Au over 23.0m (including 10.0 g/t Au over 0.55m, 3.1 g/t Au over 0.6m, and 2.1 g/t Au over 1.05m), starting at a vertical depth of 210m below surface
** 19BL-68: 3.0 g/t Au over 12.0m (including 13.3 g/t Au over 1.1m, and 8.3 g/t Au over 1.0m) starting at a vertical depth of 112m below surface

**previously released

Filling in the Gaps at the Richard Zone Extension

Hole 72, when it was released on November 13, 2019, extended the Richard Zone 91 metres southwest, and hole 78, when it was released on January 9, 2020, extended Richard a further 122m southwest (both extensions were toward the Jubilee Zone). Hole 87 succeeded in intersecting similar mineralization between these two high-grade step-out holes. In these three holes, the relatively shallow (+/- 100m vertical depth) and wide intersects align with each other (4.6 g/t Au over 29.65m in hole 72, 2.7 g/t Au over 14.1m in hole 78, and 1.2 g/t Au over 32.0m in hole 87) (Figure 2, Figure 4 and Figure 5). Similarly, the deeper and higher grade intersects also align with each other (20.7 g/t Au over 9.5m in hole 72, 20.9 g/t Au over 4.75m in hole 78, and 10.6 g/t Au over 47.0m in hole 87) (Figure 2, Figure 3 and Figure 5). Between the two mineralized intersects in each hole is low-grade waste (0.32 g/t over 25.7m in hole 72, 0.36 g/t Au over 19m in hole 78, and 0.14 g/t Au over 16.0m in hole 87). Galway's interpretation of these results, along with the tenor of other intersections further up-plunge, suggests that the mineralization is expanding to depth and the two structures may combine down-plunge.

The intersections in hole 87 are 137m and 186m, respectively, southwest of the previously released discovery hole intersection at Richard in BL18-12, which returned 7.3 g/t Au over 36.7m, including 38.1 g/t Au over 6.5m in multiple quartz veins containing abundant visible gold, starting only 51 metres downhole and 36 metres vertical. The high grade intersect in hole 12 is thought to be a different vein than the high grades seen in holes 72, 78 and 87.

The Gap Between the Richard and Jubilee Zones Has Narrowed to 350m

Hole 93, which ran 4.5 g/t Au over 10.8m, contains a section of remobilized quartz with 1-2% arsenopyrite (locally up to 10%) from 165.8 to 221.0 metres. This is at similar depths to the mineralization in holes 87 and 72 and is thought to be the same vein.

Filling in the Gaps at the Jubilee Zone Extension

The intersection of 0.8 g/t Au over 23.0m in hole 81 is located 122 metres below and west of the intersection in hole 68 of 3.0 g/t Au over 12.0m, which is the current northeastern extent of the Jubilee Zone. Hole 68, when it was released on December 2, 2019, extended the Jubilee Zone 227 metres northeast toward the Richard Zone. With results from holes 68 and 93, there is now a 350-metre gap between the Richard and Jubilee Zones.

Come and see us at the PDAC!

Galway management will be attending this year's PDAC Conference in Toronto. Core of VG from Clarence Stream and core from Estrades/Newiska will be on display at Galway's PDAC Booth #2623A on Sunday and Monday, March 1st and 2nd. Management will also be participating in the PDAC One-On-One meeting program on March 3rd and 4th. For more information please click on the link: One-on-One Meetings at PDAC.

Table 1. Assay Results

Hole ID

From
(m)

To
(m)

Intercept
(m)

Intercept
(m) TW

(Unknown if not noted)

Au
g/t

RICHARD ZONE

GWM-20BL-87

0

69.30

 
 

PENDING

 

73.00

74.00

1.00

 

0.4

 

105.00

137.00

32.00

17.40

1.2

incl.

106.85

107.55

0.70

0.40

9.9 V.G.

incl.

112.00

113.00

1.00

0.50

10.9

incl.

120.00

121.00

1.00

0.50

3.8

 

147.00

148.00

1.00

0.50

0.5

 

153.00

200.00

47.00

25.60

10.6

incl.

153.00

153.50

0.50

0.30

20.6 V.G.

incl.

176.90

177.75

0.85

0.50

35.7

incl.

187.20

196.70

9.50

5.20

44.1

incl.

187.20

188.00

0.80

0.40

21.3

incl.

189.00

189.50

0.50

0.30

495.0 V.G.

incl.

191.00

191.75

0.75

0.40

42.4

incl.

191.75

192.25

0.50

0.30

57.9

incl.

193.20

193.75

0.55

0.30

67.8

incl.

196.05

196.70

0.65

0.40

51.6

 

207.25

281.00

 
 

PENDING

GWM-20BL-93

0

178.20

 
 

PENDING

 

178.20

189.00

10.80

5.60

4.5

incl.

178.20

179.25

1.05

0.50

33.2

 

190.00

191.00

1.00

0.50

0.4

 

191.85

192.30

0.45

0.20

0.6

 

193.00

194.00

1.00

0.50

0.4

 

213.00

293.00

 
 

PENDING

GWM-19BL-81

0

73.00

 
 

PENDING

 

101.90

157.45

 
 

PENDING

 

170.15

217.30

 
 

PENDING

 

218.35

219.35

1.00

 

0.5

 

226.00

249.00

23.00

 

0.8

incl.

237.95

239.00

1.05

 

2.1

incl.

242.95

243.50

0.55

 

10.0

incl.

248.40

249.00

0.60

 

3.1

 

284.45

309.00

 
 

PENDING

(TW=True Widths); True widths are unknown if not noted; V.G.=Visible Gold; 0.42 g/t Au was used for the bottom cut-off.

Table 2: Drill Hole Coordinates

Hole ID

Azimuth

Dip

Easting

Northing

Total Depth (m)

Zone

BL19-68

320

-45

653078

5021112

267

Jubilee-Richard Trend

BL19-72

278

-85

653462

5021486

280

Richard

BL19-78

320

-75

653374

5021412

203

Richard

BL19-81

280

-68

653094

5021140

309

Jubilee-Richard Trend

BL20-87

256.5

-82

653464

5021474

281

Jubilee-Richard Trend

BL20-93

360

-90

653314

5021362

293

Jubilee-Richard Trend

Figure 1: Plan Map of the Jubilee, Richard and George Murphy Zones

Figure 2: Richard zone Plan Map

Figure 3: Richard Zone Longitudinal Section A

New Brunswick Junior Mining Assistance Program

Galway would like to acknowledge financial support from the New Brunswick Junior Mining Assistance Program, which partially funded drilling of the GMZ, Jubilee, and Richard Zones.

Geology and Mineralization

The recent discovery of the Richard Zone in hole 12 contains elevated levels of bismuth, arsenopyrite, and antimony, in multiple quartz veins, with tungsten in the vicinity. This is similar to other Clarence Stream deposits, which can be characterized as intrusion-related quartz-vein hosted gold deposits. Richard Zone contains multiple zones of quartz veining with sulfides and sericite alteration. In general, mineralization at Clarence Stream consists of 10-70% quartz stockworks and veins with 1-5% fine pyrite plus pyrrhotite plus arsenopyrite plus stibnite in sericite altered sediments. The Jubilee mineralization consists of 2%-5% disseminated pyrite, sphalerite, galena, arsenopyrite, chalcopyrite, and pyrrhotite in sediments with white to smoky grey quartz veining. Locally there is up to 10% sphalerite and semi-massive galena veinlets. The 2.5 km trend that hosts the GMZ, Richard and Jubilee Zones contains a mineralized mafic intrusive locally – similar to the South Zone, which currently hosts most of the property's last reported gold resources (September 2017). A more complete description of Clarence Stream's geology and mineralization can be found at www.galwaymetalsinc.com.

Review by Qualified Person, Quality Control and Reports

Michael Sutton, P.Geo., Director and VP of Exploration for Galway Metals, is the Qualified Person who supervised the preparation of the scientific and technical disclosure in this news release on behalf of Galway Metals Inc. All core, chip/boulder samples, and soil samples are assayed by Activation Laboratories, 41 Bittern Street, Ancaster, Ontario, Canada, who have ISO/IEC 17025 accreditation. All core is under watch from the drill site to the core processing facility. All samples are assayed for gold by Fire Assay, with gravimetric finish, and other elements assayed using ICP. The Company's QA/QC program includes the regular insertion of blanks and standards into the sample shipments, as well as instructions for duplication. Standards, blanks and duplicates are inserted at one per 20 samples. Approximately five percent (5%) of the pulps and rejects are sent for check assaying at a second lab with the results averaged and intersections updated when received. Core recovery in the mineralized zones has averaged 99%.

About the Company

Galway Metals is well capitalized with two gold projects in Canada, Clarence Stream, an emerging gold district in New Brunswick, and Estrades, the former producing, high-grade VMS mine in Quebec. The Company began trading on January 4, 2013, after the successful spinout to existing shareholders from Galway Resources following the completion of the US$340 million sale of that company. With substantially the same management team and Board of Directors, Galway Metals is keenly intent on creating similar value as it had with Galway Resources.

Should you have any questions and for further information, please contact (toll free):

Galway Metals Inc.

Robert Hinchcliffe

President & Chief Executive Officer

1-800-771-0680

www.galwaymetalsinc.com

CAUTIONARY STATEMENT: Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy of this news release. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.

This news release contains forward-looking information which is not comprised of historical facts. Forward-looking information involves risks, uncertainties and other factors that could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information. Forward-looking information in this news release includes statements made herein with respect to, among other things, the Company's objectives, goals or future plans, potential corporate and/or property acquisitions, exploration results, potential mineralization, exploration and mine development plans, timing of the commencement of operations, and estimates of market conditions. Factors that could cause actual results to differ materially from such forward-looking information include, but are not limited to, exploration results being less favourable than anticipated, capital and operating costs varying significantly from estimates, delays in obtaining or failures to obtain required governmental, environmental or other project approvals, political risks, uncertainties relating to the availability and costs of financing needed in the future, changes in equity markets, inflation, changes in exchange rates, fluctuations in commodity prices, delays in the development of projects, risks associated with the defence of legal proceedings and other risks involved in the mineral exploration and development industry, as well as those risks set out in the Company's public disclosure documents filed on SEDAR. Although the Company believes that management's assumptions used to develop the forward-looking information in this news release are reasonable, including that, among other things, the Company will be able to identify and execute on opportunities to acquire mineral properties, exploration results will be consistent with management's expectations, financing will be available to the Company on favourable terms when required, commodity prices and foreign exchange rates will remain relatively stable, and the Company will be successful in the outcome of legal proceedings, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. The Company disclaims any intention or obligation to update or revise any forward-looking information contained herein, whether as a result of new information, future events or otherwise, except as required by applicable securities laws.

SOURCE: Galway Metals Inc.

ReleaseID: 577705

Neurosity Introduces First Brain Computing Platform You Wear on Your Head to Measure Brain Waves and Host Applications Right on the Device

FCC-certified, the Notion is only device combining CPUs, Internet and brain imaging sensors to create an all-in-one computer that can run a range of apps with no laptop or smartphone required

BROOKLYN, NY / ACCESSWIRE /  February 25, 2020 / It has been a dream from science fiction to think of a command and then have it executed in the real world. Wearing a computer literally on your head until recently was the stuff of Star Trek. Now, Neurosity is announcing its Notion device, the first and only "brain-reading computer" which combines CPUs, RAM, brain sensors and Internet connectivity all in one device you wear on the back of your head. Because it includes computing power, Notion allows Neurosity and third-party developers to create never-before possible applications to run right on the ‘headwear.

Notion by Neurosity

The new Notion is shipping today to developers to help them create apps for the brain computer platform ecosystem, similar to smartphone app stores. As powerful as a MacBook Air, Notion is certified by the FCC, uses the Linux OS and includes:

Eight sensors that image the brain 250 times per second
Quad core 1.2 GHz CPU
4 GB Flash Storage
1 GB RAM
WiFi + Bluetooth
2 hours battery life
Linux OS
Dry through hair EEG sensors
Replaceable and upgradable EEG sensors

"Neuro devices that read brain waves are all the rage for early adopters, but all of them require transmitting data to an outside processor to do the computations. With advances in artificial intelligence, portable brain imaging, and powerful microchips, we are now able to derive more quantitative information about our minds than ever before," said Alex Castillo, Co-founder, Neurosity. "We are working to create a future where your thoughts power the things around you. The Notion can interpret your brain waves without the need for any other computer to execute a command."

Neurosity Notion Applications

Neurosity will be launching its own app store for the Notion, featuring Neurosity-created apps and those built by third-party developers. Neurosity has already started deploying apps for its Notion Developer Kit. One Notion app available now (for coders) is called the Developer Assistant and measures cognitive performance to reveal when and where you can write your best code, detecting your level of concentration and alertness or if you are becoming fatigued or distracted. It will automatically enable "do not disturb" mode when you are focusing so you don't get distracted by notifications.

From fatigue detection while driving a car to changing music just from your mood state, Notion will have a range of brain applications. Using the Notion Developer Kit and the Notion API, software engineers can develop apps like these:

Mind-controlled wheelchair navigation
A solution that tracks your emotional state and alerts you over time that you may be heading to a more depressed state
A tool to verify a concussion after a user has been injured in football
A program that changes the narrative of a video game depending on emotional state
Passwordless computer authentication (verification by brainwave)

Because all the computing takes place right in the device, the apps will be able to work anywhere – indoors and out – with no additional laptop or smartphone.

"These apps can be so exciting and will really transform how we interact with computers," said AJ Keller, Co-founder, Neurosity. "We see how understanding our stress, emotion and anxiety leads to a world where we can have applications that are working to help the conscious mind make sense of the subconscious. I imagine a world where you can just think about something and it happens. What kind of future would that be, where your thoughts power the things around you?"

Neurosity invites interested developers to learn more and pre-order Notion by visiting neurosity.co.

Images: https://drive.google.com/drive/folders/14Gc5j2a-JLfrkM6GjZpmT-4jDf4mJBVD

About Neurosity

Neurosity was founded in 2018 with the goal of creating a wearable brain computing platform ready for real-world applications. It has raised a pre-seed round of funding and has sold out and shipped its first batch of Notion brain computer devices to developers to help build out a robust app ecosystem. For more information visit neurosity.co.

Media Contact:

Erica Zeidenberg
erica@hottomato.net
925-518-8159 mobile
925-631-0553 office

SOURCE: Neurosity

ReleaseID: 577734